A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK.
21 Dec 2017
and the Francis Crick Institute have pinpointed 27 novel genes thought to prevent cancer from forming. Their findings could help develop personalised cancer treatments that target these genes. KU Leuven
08 Nov 2017
The rogue messengers can be detected in blood and this may lead to the development of a blood test to help identify patients more susceptible to treatment resistance
27 Sep 2017
C linical trials are fundamental to the development of new treatments for cancer, but annual accrual to studies worldwide is low, at an estimated at three to five percent.
11 Sep 2017
The loan comes from Juncker’s European Fund for Strategic Investment and will be used to develop new cancer treatments
31 Aug 2017
Subscribe to Cancer Research